Elizabeth L Hougen Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 6 days, 11 hours ago

Elizabeth L Hougen has an estimated net worth of at least $28.6 million*, as of June 10, 2026. They own 82,660 shares of IONS stock. They have sold 326,490 shares of IONS stock since 2021, for an estimated $22.4 million.

Elizabeth L Hougen $IONS SEC Form 4 Insider Trading

Elizabeth L Hougen has filed a total of 12 insider trades in $IONS since 2021. Their most recent trade was a sale of 10,172 shares, made on Mar 17, 2026. Their largest trade was a sale of 205,608 shares, made on Mar 16, 2026. We estimate that they now own 82,660 shares of $IONS, worth an estimated $6.2 million.

Insider Trading at $IONS

There have been a total of 301 insider trades reported at $IONS since 2021, with 20,000 shares purchased and 3.2 million shares sold. The most active insider traders in $IONS stock have been Brett P Monia, Eric Swayze, and Patrick R. O'Neil. The most recent trade was a sale of 19,842 shares reported by Holly B. Kordasiewicz (EVP, Chief Development Officer), made on Jun 12, 2026.

History of Insider Stock Trades by Elizabeth L Hougen

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
IONS	Sale	10,172	Mar 17, 2026	March 18, 2026, 5:19 p.m.
IONS	Sale	9,440	Mar 16, 2026	March 18, 2026, 5:19 p.m.
IONS	Sale	205,608	Mar 16, 2026	March 18, 2026, 5:19 p.m.
IONS	Sale	6,988	Jan 30, 2026	Feb. 2, 2026, 9:51 p.m.
IONS	Sale	12,922	Jan 16, 2026	Jan. 20, 2026, 9:18 p.m.
IONS	Sale	49,800	Sep 30, 2025	Oct. 1, 2025, 4:55 p.m.
IONS	Sale	1,523	Jan 31, 2025	Feb. 3, 2025, 8:26 p.m.
IONS	Sale	8,870	Jan 16, 2025	Jan. 17, 2025, 8:40 p.m.
IONS	Sale	2,125	Feb 02, 2024	Feb. 2, 2024, 8:55 p.m.
IONS	Sale	8,683	Jan 17, 2024	Jan. 18, 2024, 6:48 p.m.
IONS	Sale	2,079	Feb 06, 2023	Feb. 7, 2023, 6:36 p.m.
IONS	Sale	8,280	Jan 18, 2023	Jan. 19, 2023, 9:19 p.m.

$IONS Executives and Stock Owners with Insider Trades

Brett P Monia, Chief Executive Officer
Eric Swayze, EVP Research
Patrick R. O'Neil, EVP CLO & General Counsel
Richard S Geary, EVP, Chief Development Officer
Joseph Baroldi, EVP, Chief Business Officer
C Frank Bennett, EVP, Chief Scientific Officer
Shannon L. Devers, EVP, Chief Human Resources Ofc
Eugene Schneider, EVP, Chf Clinical Develop Ofcr
Elizabeth L Hougen, EVP, Finance & CFO
Brian Birchler, EVP, Corp and Development Ops
Onaiza Cadoret-Manier, EVP, Chf GL Pdt Str & Oper Ofc
Holly B. Kordasiewicz, EVP, Chief Development Officer
Kyle Jenne, EVP, Chf GL Pdt Str Ofcr

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.